Therapeutic Effect of Recombinant Adenovirus Encoding Interferon-γ in a Murine Model of Progressive Pulmonary Tuberculosis (Q45864483)

17 December 2017

title

Therapeutic Effect of Recombinant Adenovirus Encoding Interferon-γ in a Murine Model of Progressive Pulmonary Tuberculosis (English)

1 reference

17 December 2017

1 reference

1 reference

Dulce A Mata-Espinosa

1

1 reference

17 December 2017

Valentin Mendoza-Rodríguez

2

1 reference

17 December 2017

Diana Aguilar-León

3

1 reference

17 December 2017

Ricardo Rosales

4

1 reference

17 December 2017

Fernando López-Casillas

5

1 reference

17 December 2017

Rogelio Hernández-Pando

6

1 reference

17 December 2017

publication date

1 June 2008

1 reference

17 December 2017

published in

Molecular Therapy

1 reference

17 December 2017

volume

16

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

1065-1072

1 reference

17 December 2017

cites work

Immunity to tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Immunology of tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Chronic bacterial infections: living with unwanted guests

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Cellular responses to interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Interferon-gamma and interleukin-12 pathway defects and human disease

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Immune response in mice that lack the interferon-gamma receptor

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Nitric oxide and the immune response

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Disseminated tuberculosis in interferon gamma gene-disrupted mice

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Intratracheal interferon-gamma augments pulmonary defenses in experimental legionellosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Local activation of nonspecific defense against a respiratory model infection by application of interferon-gamma: comparison between rat alveolar and interstitial lung macrophages.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Interferon-gamma for respiratory diseases

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Inhaled IFN-gamma for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-gamma deficiency

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Adenovirus vectors for high-efficiency gene transfer into mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Adenoviruses as vaccine vectors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Expression of inducible nitric oxide synthase and nitrotyrosine during the evolution of experimental pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

IFN-γ and NO in mycobacterial disease: new jobs for old hands

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Anti-inflammatory properties of pro-inflammatory interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Immunotherapeutics for tuberculosis in experimental animals: is there a common pathway activated by effective protocols?

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Receptor-mediated targeting of gene delivery vectors: insights from molecular mechanisms for improved vehicle design

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Cloning and expression of murine immune interferon cDNA

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

The Use of Fluorescein Diacetate and Ethidium Bromide as a Stain for Evaluating Viability of Mycobacteria

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

In situ analysis of lung antigen-presenting cells during murine pulmonary infection with virulent Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.69

7 January 2021

Identifiers

DOI

10.1038/MT.2008.69

1 reference

17 December 2017

1 reference

17 December 2017